Results 211 to 220 of about 25,193 (261)
Some of the next articles are maybe not open access.
Neonatal Network, 2000
THE NICU EXPOSES NEONATES TO REPEATED AND RANDOM events. Touch is often procedure oriented. Excessive noise and bright lights may disrupt sleep-wake cycles. Inappropriate sensory stimuli may lead to immediate signs of stress and discomfort. The impact of these events on brain development during this critical period is undetermined.
openaire +2 more sources
THE NICU EXPOSES NEONATES TO REPEATED AND RANDOM events. Touch is often procedure oriented. Excessive noise and bright lights may disrupt sleep-wake cycles. Inappropriate sensory stimuli may lead to immediate signs of stress and discomfort. The impact of these events on brain development during this critical period is undetermined.
openaire +2 more sources
Lorazepam in status epilepticus
Annals of Neurology, 1979AbstractLorazepam, a dichloro‐3‐hydroxy‐1,4‐benzodiazepine, has been shown to be a potent anticonvulsant in animal models of epilsepsy and has minimal depressant effects on respiration and circulation in humans. The effects of this compound were studied in status epilepticus.
Michael R. Vasko +6 more
openaire +3 more sources
Lorazepam for psychogenic catatonia
American Journal of Psychiatry, 1987Catatonia poses special diagnostic and management problems for the psychiatrist. The authors report three patients with psychogenic catatonia who received intramuscular lorazepam and experienced rapid resolution of their conditions.
Thomas P. Beresford +2 more
openaire +3 more sources
Lorazepam in the treatment of neurosis
Current Medical Research and Opinion, 1976An open study was carried out in 40 ambulatory neurotic patients with classical symptoms of anxiety to assess which of their symptoms responded most readily and favourably to treatment with lorazepam. Doses ranged from 2 mg to 15 mg daily and were adjusted to individual patient needs.
openaire +3 more sources
Journal of Pharmaceutical Sciences, 1982
Ten healthy volunteers received single 2-mg doses of lorazepam on five occasions in random sequence. Modes of administration were: A, intravenous injection; B, deltoid intramuscular injection; C, oral tablets in the fasting state; D, sublingual dosage of oral tablets in the fasting state; and E, sublingual dosage of specially formulated tablets in the ...
Marcia Divoll +3 more
openaire +3 more sources
Ten healthy volunteers received single 2-mg doses of lorazepam on five occasions in random sequence. Modes of administration were: A, intravenous injection; B, deltoid intramuscular injection; C, oral tablets in the fasting state; D, sublingual dosage of oral tablets in the fasting state; and E, sublingual dosage of specially formulated tablets in the ...
Marcia Divoll +3 more
openaire +3 more sources
Section C Lorazepam in anaesthesia
Current Medical Research and Opinion, 1973SummaryLorazepam has been studied in 212 patients for use as a night-time sedative and for pre-operative medication. Sixty-four of the patients participated in an open pilot trial using lorazepam, and 148 patients formed part of a double-blind trial of lorazepam and diazepam. Each patient was given 2 mg.
openaire +3 more sources
HPLC determination of lorazepam and lorazepam-related compounds in pharmaceutical formulations
Chromatographia, 2000A sensitive, accurate and reproducible high performance liquid chromatographic (HPLC) procedure has been developed for the separation and analysis of lorazepam and related compounds. A 20-μL sample was separated by reversed-phase HPLC on a 150 mm ×4.6 mm, 5-μm particle, Wakosil column with 0.1m ammonium acetate (pH adjusted to 6.0 with acetic acid ...
Orlović, D +3 more
openaire +4 more sources
Lorazepam in the treatment of anxiety
Current Medical Research and Opinion, 1972SummaryA double-blind study in 50 patients suffering from anxiety was carried out using lorazepam, a new benzodiazepine, and diazepam. The two drugs appeared to be equally effective in all respects and no drug-induced changes were noted from urine examination or in blood-pressure recordings.
openaire +2 more sources
Catatonia Associated With Lorazepam Withdrawal
Psychosomatics, 1997Catatonia is a heterogeneous syndrome that varies in etiology, presentation, course, and sequelae. Some have suggested conceptualizing catatonia as malignant when associated with autonomic instability or hyperthermia and simple in the absence of these signs.· Whereas malignant catatonia is a potentially lethal medical emergency, simple catatonia may be
Susan G. Glover +3 more
openaire +3 more sources
Lorazepam for Chemotherapy-Induced Emesis
Archives of Internal Medicine, 1984To the Editor. —Stoudemire et al 1 eloquently described the difficult clinical problem of managing chemotherapy-induced emesis. Our experience with lorazepam suggests it is satisfactory for use even in regimens using cisplatin and in patients who previously suffered from anticipatory nausea and vomiting. 2 Lorazepam is a benzodiazepine with sedative,
R.S. Leuchter +2 more
openaire +3 more sources